Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolactin in systemic lupus erythematosus

R Pauzner1, M B Urowitz, D D Gladman

  • 1University of Toronto Rheumatic Disease Unit, Wellesley Hospital, ON, Canada.

The Journal of Rheumatology
|November 1, 1994
PubMed
Summary

Hyperprolactinemia, elevated prolactin levels, does not appear to be linked to disease activity in systemic lupus erythematosus (SLE). Further research is needed for patients with unexplained hyperprolactinemia in SLE.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Declining levels of serum chemokine (C-X-C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?

The British journal of dermatology·2020
Same author

Disease course patterns in systemic lupus erythematosus.

Lupus·2018
Same author

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.

Arthritis research & therapy·2018
Same author

Severe brady-arrhythmias in systemic lupus erythematosus: prevalence, etiology and associated factors.

Lupus·2018
Same author

Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies.

Lupus·2018
Same author

Antimalarial-induced cardiomyopathy: a systematic review of the literature.

Lupus·2017

Area of Science:

  • Endocrinology
  • Rheumatology
  • Immunology

Background:

  • Hyperprolactinemia is a condition characterized by elevated prolactin levels.
  • The relationship between hyperprolactinemia and autoimmune diseases like systemic lupus erythematosus (SLE) requires further investigation.
  • Understanding potential associations can inform clinical management and research directions.

Purpose of the Study:

  • To determine the prevalence of hyperprolactinemia in patients with SLE.
  • To evaluate the clinical significance of hyperprolactinemia concerning disease activity in SLE.
  • To explore potential links between unexplained hyperprolactinemia and SLE activity.

Main Methods:

  • Analysis of basal prolactin levels and clinical data in 82 consecutive SLE patients.
  • Inclusion of longitudinal studies in a subset of 30 patients to assess disease activity over time.
  • Statistical analysis to correlate hyperprolactinemia with SLE disease activity.

Main Results:

  • Hyperprolactinemia was not significantly associated with overall disease activity in the SLE cohort (p = 0.145).
  • Longitudinal data from 30 patients also showed no significant link between hyperprolactinemia and disease activity (p = 0.294).
  • A trend suggested SLE activity might be more common in patients with unexplained hyperprolactinemia compared to those with secondary causes (p = 0.088).

Conclusions:

  • Hyperprolactinemia is unlikely to be a direct indicator of disease activity in systemic lupus erythematosus.
  • The findings suggest that the clinical significance of hyperprolactinemia in SLE may be limited.
  • Further investigation into unexplained hyperprolactinemia in SLE patients is warranted to clarify its role, if any.

Related Experiment Videos